Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain: Promoting Engagement in Cognitive Behavioral Therapy
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 16 Years to 39 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether digital cognitive behavioral therapy, which teaches skills to manage pain, can reduce pain, opioid pain medicine use, and health care visits. It is for people ages 16 to 39 with sickle cell disease. The study also looks at whether personal support from peers helps people use the therapy and get better results.
The study, known as the Peer suppoRt for adolescents and Emerging adults with Sickle cell pain: promoting ENgagement in Cognitive behavioral thErapy (PRESENCE), aims to determine the effectiveness of digital CBT in reducing pain, opioid use, and healthcare utilization among AYAs with SCD. It also seeks to understand the role of personalized peer support in enhancing engagement and outcomes of digital CBT interventions. By leveraging existing infrastructure for delivering virtual peer support interventions, tailored digital CBT programs for individuals with SCD, and partnerships with CBOs, the study aims to provide valuable insights into the feasibility and effectiveness of digital CBT as a pain management strategy for this vulnerable population.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- You are 16 to 39 years old when you join.
- You have any type of sickle cell disease, confirmed by a referral or records.
- For at least 3 months, on 4 or more days each week, you have had pain, been prescribed pain medicine, taken pain medicine, or received pain treatment without medicine.
- You have access to an iOS or Android mobile device with internet access.
Who can't join
- You cannot speak or read English.
- You have had a stem cell transplant for sickle cell disease, which replaces blood-forming cells.
- You do not live in the United States when you join and throughout the study.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: 1. Aged 16 to 39 years of age at time of enrollment 2. Sickle Cell Disease diagnosis of any genotype based on referral or documentation 3. Reports chronic pain (≥4 days/week for past 3 months or more) OR A) Being prescribed pain medication to be taken (≥4 days/week for past 3 months or more) OR B) Taking pain medication (≥4 days/week for past 3 months or more) OR C) Receiving non-pharmaceutical pain treatment (≥4 days/week for past 3 months or more) 4. Access to an iOS or Android mobile device with internet access Exclusion Criteria: 1. Unable to speak or read English 2. Prior hematopoietic stem cell transplant for sickle cell disease 3. Not living in the United States throughout enrollment and duration of the study period
Study sites (14)
AL
- University of South Alabama Medical Center · Mobile, AL 36617Jessica King · Study contact · (251) 445-9159 · jlking@health.southalabama.eduT'Shemika Perryman · Study contact · tperryman@health.southalabama.eduAntwan Hogue, MD · Principal investigatorArdie Pack-Mabien, PhD · Sub-investigatorMore trials in Mobile
CA
- UCLA Mattel Children's Hospital Ronald Reagan Hospital · Los Angeles, CA 90095Debbie Argueta Rufino · Study contact · (424) 362-0037 · darguetarufino@mednet.ucla.eduSatiro De Oliveira, MD · Principal investigatorMore trials in Los Angeles
CT
- Connecticut Children's Medical Center · Hartford, CT 06106Christopher Theriault · Study contact · (860) 837-5852 · ctheriault@connecticutchildrens.orgWilliam Zempsky, MD · Principal investigatorMore trials in Hartford
GA
- Children's Healthcare of Atlanta · Atlanta, GA 30345Katyria Thornton · Study contact · (404) 785-6274 · katyria.thornton@choa.orgVontarius Howard Jesse · Study contact · (404) 785-3245 · vontarius.howard@choa.orgCarlton Dampier, MD · Principal investigatorMore trials in Atlanta
IL
- Ann and Robert H. Lurie Children's Hospital of Chicago · Chicago, IL 60611Kevin Guerrero · Study contact · (312) 227-4824 · kguerrero@lueriechildrens.orgRobert Liem, MD · Principal investigatorMore trials in Chicago
MI
- The Regents of the University of Michigan · Ann Arbor, MI 48109-1079Anela Mukherjee · Study contact · 7342329896 · mukherja@med.umich.eduEric Scott, PhD · Principal investigatorMore trials in Ann Arbor
NC
- Wake Forest Baptist Hospital · Durham, NC 27106Julie Fountain · Study contact · (980) 442-2000 · Julie.Fountain@Advocatehealth.orgAlex George, MD · Principal investigatorMore trials in Durham
- East Carolina University Health Medical Center · Greenville, NC 27834Toria Wilson · Study contact · (252) 744-0493 · wilsonto22@ecu.eduDarla Liles, MD · Principal investigatorMore trials in Greenville
NJ
- Rutgers New Jersey Medical School · Newark, NJ 07103Kim White · Study contact · (732) 277-7703 · whiteka@rwjms.rutgers.eduAshwin Sridharan, MD · Principal investigatorMore trials in Newark
NY
- Weil Cornell Medical College · New York, NY 10065Masiel Infante · Study contact · 646-962-8311 · mai4011@med.cornell.eduMaria DeSancho, MD · Principal investigatorMore trials in New York
- University of Rochester Medical Center · Rochester, NY 14642Priya Kaushal · Study contact · (585) 275-2981 · priya_kaushal@urmc.rochester.eduSuzie Noronha, MD · Principal investigatorMore trials in Rochester
PA
- UPMC University of Pittsburgh Classical Hematology Adult Clinic · Pittsburgh, PA 15213Steffi Siebert, MPH · Study contact · 8776490176 · presencestudy@pitt.eduLaura De Castro, MD · Principal investigatorAna Radovic, MD · Principal investigatorMore trials in Pittsburgh
- UPMC Children's Hospital of Pittsburgh · Pittsburgh, PA 15224Alex Berkebile · Study contact · 412-692-5964 · berkebileak@upmc.eduAmy Travis · Study contact · 412-692-8575 · travisam@upmc.eduDr. Cheryl Hillery, MD · Principal investigatorMore trials in Pittsburgh
VA
- Virginia Commonwealth University · Richmond, VA 23284Danie Sop, PhD · Study contact · (804) 828-0810 · daniel.sop@vcuhealth.orgWally Smith, MD · Principal investigatorMore trials in Richmond